DJIA 16,493.97 -7.68 -0.05%
NASDAQ 4,143.18 16.21 0.39%
S&P 500 1,877.95 2.56 0.14%
market minute promo

2.99 0.00 (0.00%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

TSPT $2.99 0.00%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $3.01
Previous Close $2.99
Daily Range $2.94 - $3.03
52-Week Range $2.52 - $4.23
Market Cap $56.3M
P/E Ratio -2.05
Dividend (Yield) $0.00 (0.0%)
Volume 38,193
Average Daily Volume 45,657
Current FY EPS $0.00

Sector

Healthcare

Industry

Drugs

Transcept Pharmaceuticals (TSPT) Description

Transcept Pharmaceuticals Inc. is a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in neuroscience. Website: http://www.transcept.com/

News & Commentary

Can't Sleep? Don't Worry, You're Not Alone

Roughly 100 million people in the U.S. exhibit signs of insomnia each year, but many of the treatments available to treat this disorder have been nothing short of a disappointment.

Transcept Pharmaceuticals Issues Statement on Dismissal of Derivative Lawsuit

Transcept Pharmaceuticals Statement on the Withdrawal of Retrophin's $4.00/Share Offer

Transcept Pharmaceuticals Announces Roumell Asset Management Supports Company Strategies

Transcept Provides Update to Key Initiatives to Increase Stockholder Value

Transcept Pharmaceuticals' CEO Discusses Q3 2013 Results - Earnings Call Transcript

Transcept Pharmaceuticals, Inc. Discusses Q3 2013 Results (Webcast)

4 Stocks Under $10 Making Big Moves

Transcept Pharma Says Received Request by Retrophin to Buy Up to 15% of Outstanding Shares, Board De

Transcept Pharma Says Received Request by Retrophin to Buy Up to 15% of Outstanding Shares, Board Decided Not to Accede Request

Benzinga's M&A Chatter for Wednesday September 18, 2013

5 Stocks Under $10 Set to Soar

See More TSPT News...

TSPT's Top Competitors

TSPT $2.99 (0.00%)
Current stock: TSPT
AMGN $114.05 (0.65%)
Current stock: AMGN
GILD $73.79 (-0.09%)
Current stock: GILD
BIIB $293.57 (-4.30%)
Current stock: BIIB